# Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis

> **NCT01305837** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 30 (actual)

## Conditions studied

- Progressive Multiple Sclerosis

## Interventions

- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT01305837
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305837, "Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01305837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*